A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

Autor: Han, Sileny N., Oza, Amit, Colombo, Nicoletta, Oaknin, Ana, Raspagliesi, Francesco, Wenham, Robert M., Braicu, Elena Ioana, Jewell, Andrea, Makker, Vicky, Krell, Jonathan, Alía, Eva María Guerra, Baurain, Jean-François, Su, Zhenqiang, Neuwirth, Rachel, Vincent, Sylvie, Sedarati, Farhad, Faller, Douglas V., Scambia, Giovanni
Zdroj: In Gynecologic Oncology November 2023 178:110-118
Databáze: ScienceDirect
Externí odkaz: